Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.
- NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_assertion description "[Although the most widely studied genes are the cell-cycle inhibitors p15INK4b and p16INK4a (specially in AML and ALL), the list of methylation-repressed genes in these neoplasms is expanding very rapidly, including MGMT, RARB2, CRBP1, SOCS-1, CDH1, DAPK1, and others.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.
- NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_assertion evidence source_evidence_literature NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.
- NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_assertion SIO_000772 14585279 NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.
- NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_assertion wasDerivedFrom befree-2016 NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.
- NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_assertion wasGeneratedBy ECO_0000203 NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.
- befree-2016 importedOn "2016-02-19" NP418691.RAYkdGxY29HUefbsW7wb8RVL4ixL8vFgrzXfNVKpABBNE130_provenance.